by Cort Johnson | Aug 12, 2020 | Epstein-Barr Virus, Homepage, Pathogens
An old drug called spironolactone opens the door to a new generation of more effective Epstein-Barr virus drugs that could help with chronic fatigue syndrome, long COVID and other diseases.
by Cort Johnson | Aug 5, 2020 | COVID-19, Homepage, long COVID
A couple of weeks ago Health Rising posted a kind of wakeup call for the COVID-19 long haulers. Borne out of decades of experience with ME/CFS, it was admittedly a pretty harsh piece – not easy to take in. An Open Letter to the COVID-19 Long Hauler Community...
by Cort Johnson | Jul 24, 2020 | COVID-19, Homepage
“If you look anecdotally, there is no question that there are a considerable number of individuals who have a post-viral syndrome that in many respects incapacitates them for weeks and weeks following so-called recovery. They report symptoms such as brain fog,...
by Cort Johnson | Jul 22, 2020 | Epstein-Barr Virus, Pathogens
In a surprise a 50 year old drug called Spironolactone points the way to a new generation of Epstein-Barr virus and probaby herpesvirus drugs as well.
by Cort Johnson | Jul 18, 2020 | Epstein-Barr Virus, Pathogens
Active Epstein-Barr Virus infections found in a substantial number of people with chronic fatigue syndrome (ME/CFS)
by Cort Johnson | Jul 11, 2020 | Homepage, Neuroinflammation, Pathogens, Small Fiber Neuropathy
High rates of alterations in the genes that produce mucosal proteins suggest that a damaged mucous layer in the eyes, nose or upper respiratory systems of people with chronic fatigue syndrome could be providing pathogens or toxins easier entry - possibly producing neuroinflammation and central sensitization.